Editas Medicine (EDIT) Prepaid Assets (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Prepaid Assets of $2.1 million for Q4 2025, down 33.86% year-over-year from $3.1 million in Q4 2024, and down 33.38% quarter-over-quarter from $3.1 million in Q3 2025.
Editas Medicine (EDIT) Prepaid Assets (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Prepaid Assets for 11 consecutive years, with $2.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets fell 33.86% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 33.86% YoY), while the FY2025 annual figure was $2.1 million, down 33.86% from the prior year.
- Prepaid Assets slipped to $2.1 million in Q4 2025 per EDIT's latest filing, from $3.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.5 million in Q3 2021 and bottomed at $2.1 million in Q4 2025.
- Historically, Prepaid Assets has averaged $6.1 million across 5 years, with a median of $6.6 million in 2023.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 58.2% — and 2025, when it tumbled 63.14%.
- Editas Medicine's Prepaid Assets stood at $7.2 million in 2021, then rose by 1.9% to $7.3 million in 2022, then rose by 2.67% to $7.5 million in 2023, then tumbled by 58.36% to $3.1 million in 2024, then plunged by 33.86% to $2.1 million in 2025.
- Business Quant data shows EDIT's Prepaid Assets at $2.1 million in Q4 2025, $3.1 million in Q3 2025, and $3.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 5.93 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 9.14 Mn |
| Dec 31, 2023 | 7.53 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 5.78 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 9.52 Mn |
| Jun 30, 2021 | 5.41 Mn |
| Mar 31, 2021 | 6.31 Mn |